State with unexpected no red ink7/2/2023 ![]() All the while, I was able to keep doing what needed to be done: write a book, raise a child, teach my classes.īut none of this gets around a single, stubborn fact. My insurance paid large sums for tests and treatments my family and friends were patient and supportive. They pushed me along to the nation’s greatest experts, at the finest medical institutions. From the first, doctors took my condition seriously, sometimes more seriously than I did. They spend years going from doctor to doctor, in a desperate search for someone, anyone, who’s willing to help. ![]() Far too often, women who present with hard-to-diagnose illnesses are told that the symptoms are no big deal, that the problem is in their head. There are PowerPoint decks about it.Īll of which makes me lucky, in one respect. It has been debated at hospital grand rounds and global medical conferences, and in high-powered conference calls. In the past few years, my case has been examined by specialists at Yale, Harvard, Columbia, and the University of Pennsylvania-by immunologists, rheumatologists, dermatologists, pulmonologists, and experts in infectious disease. At the N.I.H., Ombrello’s team took twenty-one vials of my blood and stored a few of them in liquid nitrogen for future use. That spring, I became the research subject. As a historian and a biographer, I am used to conducting research, examining other people’s lives in search of patterns and insights. That’s how I ended up as a patient in his clinic on a sweet, warming day in April, 2021, just as the cherry blossoms in the Washington area were in full bloom. ![]() campus, in Bethesda, Maryland, to study her case first hand. Even more puzzling was the sudden onset of severe joint pain and swelling she was experiencing after years of excellent health. It was hard to discern how the patient, a forty-eight-year-old woman, had survived for so long without serious infections. A specialist in rare inflammatory and immune disorders, Ombrello was concerned by what first-round genetic tests showed: a disabling mutation in a gene, known as PLCG2, that’s crucial for proper immune functioning. Michael Ombrello, an investigator at the National Institutes of Health, received a message from doctors at Yale about a patient with a novel genetic mutation-the first of its kind ever seen. ![]()
0 Comments
Leave a Reply. |